Serodus Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • IPO
  • Latest Deal Amount
  • $699K
Latest Deal Amount

Serodus General Information


Developer of pharmaceuticals for treatment of diseases in the heart and blood vessels. The company focuses on new therapeutic products for the treatment of cardiovascular diseases with large unmet clinical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Gaustadalleen 21
  • 0349 Oslo
  • Norway
+47 22 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Serodus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. IPO 09-Apr-2013 $699K 00.000 Completed Generating Revenue
2. Early Stage VC 01-Dec-2011 00.000 00.000 Completed Startup
1. Early Stage VC 19-Feb-2010 $864K $864K Completed Startup
To view Serodus’s complete valuation and funding history, request access »

Serodus Executive Team (4)

Name Title Board Seat Contact Info
Eva Steiness MD Chief Executive Officer
Tore Kvam Chief Financial Officer
Trygve Gulbrandsen Chief Scientific Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Serodus Board Members (6)

Name Representing Role Since
Ingrid Alfheim Ph.D Self Board Member 000 0000
Ole Nordby Self Board Member 000 0000
Søren Elmann Ingerslev Self Board Member 000 0000
Svein Jacobsen Self Chairman 000 0000
Terri Sebree Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Serodus Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Serodus Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 10-Jul-2013 000000000000000000 00000 Pharmaceuticals 000 00000000 00
To view Serodus’s complete acquisitions history, request access »